title: Methylnaltrexone to Palliate Pruritus in Terminal Hepatic Disease.
authors.forename: Christopher M
authors.initials: CM
authors.lastname: Hohl
authors.forename: Jonathan K
authors.initials: JK
authors.lastname: Wong
authors.forename: Michael S
authors.initials: MS
authors.lastname: Harlos
mesh_terms: D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000150:complications; D017809:Fatal Outcome; D005260:Female; D005706:Gallbladder Neoplasms / Q000150:complications; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D008113:Liver Neoplasms / Q000150:complications; D008297:Male; D008875:Middle Aged; D009271:Naltrexone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D010147:Pain Measurement; D011537:Pruritus / Q000188:drug therapy* / Q000209:etiology*; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D013727:Terminal Care
chemical_list: D009292:Narcotic Antagonists; D000644:Quaternary Ammonium Compounds; C032257:methylnaltrexone; D009271:Naltrexone